For $25 a month you get five (5!) WeedWeek stickers, discounts to all future WeedWeek events, a postcard from Los Angeles, cannabis capital of the world and you get to join a monthly Google hangout with me and other WeedWeek supporters to discuss the latest news…

Brandbuilding opportunities to appear in the newsletter with your links and social media handles start at only $50 a month.

In other WeedWeek news:

WeedWeek is introducing a new feature called WeedWeek Forum. Think of it as the cannabis world’s Op-Ed page. Many of you are are eager to share your thoughts and expertise. Here’s your chance to publish on the WeedWeek site.

Several outlets already publish similar work. Unfortunately their credibility suffers from the perception, if not the reality, that contributors can pay to be featured. WeedWeek will not accept payment for publishing work. We won’t pay you either (at least at first.)

WeedWeek Forum will strive to publish pieces based on their merits and relevance. Getting your essay in WeedWeek, is a form of earned media, or, as it’s sometimes called, thought leadership.

Pro-legalization Congressman Earl Blumenauer (D-Ore.) is trying to defeat anti-legalization Congressman Pete Sessions (R-Texas). “We’re going to be putting up some billboards in Pete Sessions’s district,” Blumenauer said. “It’s going to feature a veteran and ask the question why Pete Sessions doesn’t want him to have access to his medicine.”

New Jersey Senator and possible 2020 presidential contender Cory Booker (D) discussed why legalization is his signature issue. Current enforcement, he says, “makes a mockery” of equal justice under the law. Booker says he has never smoked cannabis or drank alcohol.

The Boston Globe asks if towns which ban dispensaries should still get their share of tax revenue. Globe reporter Dan Adams then criticized Snoop Dogg’s media company, Merry Jane, for stealing the content of his story, “like a high school plagiarist.”

According to Viridian Capital Advisors, cannabis companies raised more than $1.8 billion in the first three quarters of 2017, up from $720M last year. The average deal size also increased from $3M to $6.7M.

Rep. Tom Marino (R-Pa.) withdrew from consideration to be drug czar after the Washington Post and 60 Minutes revealed he steered legislation through Congress weaking the DEA’s ability to go after distributors of pharmaceutical opiates. Chris Christie and Harvard Medical School psychiatry professor Bertha Madras have been mentioned as possible replacements.

Florida attorney general and Trump ally Pam Bondi questioned whether the country needs a drug czar.

In a brief, Justice Department lawyers acknowledged it hadn’t been legal for the department to spend money prosecuting the Washington MED defendants known as the Kettle Falls Five, since December 2014, on account of the Rohrabacher-Farr Amendment. The amendment, now known as Rohrabacher-Blumenauer, could expire in December.